Virtu Financial LLC Invests $46,000 in Quantum Biopharma Ltd. (NASDAQ:QNTM)

Virtu Financial LLC acquired a new stake in Quantum Biopharma Ltd. (NASDAQ:QNTM) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,428 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned 0.60% of Quantum Biopharma at the end of the most recent quarter.

Quantum Biopharma Stock Down 13.3 %

Shares of QNTM stock opened at $3.00 on Friday. The stock has a market capitalization of $5.76 million, a P/E ratio of -0.19 and a beta of 0.59. The stock’s 50-day moving average price is $4.92. Quantum Biopharma Ltd. has a 12 month low of $2.70 and a 12 month high of $70.85.

Quantum Biopharma Company Profile

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments.